ES8104232A1 - Procedimiento para preparar nuevos compuestos de quinolona - Google Patents

Procedimiento para preparar nuevos compuestos de quinolona

Info

Publication number
ES8104232A1
ES8104232A1 ES489929A ES489929A ES8104232A1 ES 8104232 A1 ES8104232 A1 ES 8104232A1 ES 489929 A ES489929 A ES 489929A ES 489929 A ES489929 A ES 489929A ES 8104232 A1 ES8104232 A1 ES 8104232A1
Authority
ES
Spain
Prior art keywords
hydrogen
lower alkyl
methyl
alkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES489929A
Other languages
English (en)
Other versions
ES489929A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of ES489929A0 publication Critical patent/ES489929A0/es
Publication of ES8104232A1 publication Critical patent/ES8104232A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE QUINOLONA, DE FORMULA (I), DONDE R1, R2, R3, R4, Y R5 SON DISTINTOS TIPOS DE RADICALES; N ES 0, 1 O 2. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O UN ILURO DE FORMULA (III), CON UN ESTER ORTOFORMIATO; M ES 0 O 1. ESTOS COMPUESTOS SE EMPLEAN PARA REDUCIR LA PRESION SANGUINEA. *FORMULA*
ES489929A 1979-03-27 1980-03-26 Procedimiento para preparar nuevos compuestos de quinolona Expired ES8104232A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27

Publications (2)

Publication Number Publication Date
ES489929A0 ES489929A0 (es) 1981-04-16
ES8104232A1 true ES8104232A1 (es) 1981-04-16

Family

ID=10504143

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489929A Expired ES8104232A1 (es) 1979-03-27 1980-03-26 Procedimiento para preparar nuevos compuestos de quinolona

Country Status (10)

Country Link
JP (2) JPS55130960A (es)
BE (1) BE882443A (es)
CY (1) CY1343A (es)
ES (1) ES8104232A1 (es)
GB (1) GB2047691B (es)
GE (1) GEP19970835B (es)
JO (1) JO1072B1 (es)
MX (1) MX5950A (es)
SU (1) SU1124886A3 (es)
ZA (1) ZA801575B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents

Also Published As

Publication number Publication date
MX5950A (es) 1993-11-01
GEP19970835B (en) 1997-02-10
BE882443A (fr) 1980-09-26
JPS62215526A (ja) 1987-09-22
ES489929A0 (es) 1981-04-16
JPH0114224B2 (es) 1989-03-10
GB2047691B (en) 1983-07-20
CY1343A (en) 1987-01-16
ZA801575B (en) 1981-03-25
JPH0250086B2 (es) 1990-11-01
JPS55130960A (en) 1980-10-11
JO1072B1 (en) 1982-07-10
SU1124886A3 (ru) 1984-11-15
GB2047691A (en) 1980-12-03

Similar Documents

Publication Publication Date Title
SE8002345L (sv) Terapeutiska medel
IL104614A (en) 4-benzoylisoxazole derivatives and herbicidal compositions comprising them
ES8105248A1 (es) Procedimiento para preparar derivados de trifenilalqueno
ES8102137A1 (es) Procedimiento para la obtencion de vinil-3 cefalosporinas
AU550315B2 (en) Substituted 2:-phenyl-ethyl-1h-1,24-triazole
ES8102136A1 (es) Procedimiento para la obtencion de derivados de vinil-3 ce- falosporina
ES475635A1 (es) Procedimiento para preparar derivados de imidazol.
ES8104232A1 (es) Procedimiento para preparar nuevos compuestos de quinolona
ES8504103A1 (es) Un procedimiento para preparar derivados de ciclobutano
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES8103573A1 (es) Procedimiento para la preparacion de fenoxi y tiofenoxinitrilos.
JPS57128674A (en) Growth regulant alpha-azolylglycol, manufacture and plant growth regulant containing same
ES485492A1 (es) Un procedimiento para preparar derivados de triazol
ES8304973A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
ES8105319A1 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
ES468532A1 (es) Un procedimiento para preparar un compuesto de sulfonio re- gulador del crecimiento de las plantas
ES441437A1 (es) Procedimiento para la preparacion de crotonanilidas susti- tuidas.
NZ180968A (en) 3-imino-1-phenylbenz-2-2,4-thiazepines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990301